[
    {
      "id": 1,
      "title":"A Study Of Palbociclib + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer",
      "created_by": "Dr.Jane Anderson",
      "description": "The study is designed to compare the clinical benefit following treatment with letrozole in combination with Palbociclib versus letrozole in combination with placebo in Asian postmenopausal women with ER(+)/HER2(-) advanced breast cancer who have not received prior systemic anti cancer therapies for their advanced/metastatic disease.",
      "Condition": "B+ve",
      "Sponsor": "Nagercoil",
      "Identified": 14521,
      "Pre-Screened": 13571,
      "Qualified":1524,
      "Enrolled":2457
    },
      {
      "id": 2,
      "title":"A Study Of Palbociclib + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer",
      "created_by": "Dr.Jane Anderson",
      "description": "The study is designed to compare the clinical benefit following treatment with letrozole in combination with Palbociclib versus letrozole in combination with placebo in Asian postmenopausal women with ER(+)/HER2(-) advanced breast cancer who have not received prior systemic anti cancer therapies for their advanced/metastatic disease.",
      "Condition": "B+ve",
      "Sponsor": "Nagercoil",
      "Identified": 1,
      "Pre-Screened": 1,
      "Qualified":1,
      "Enrolled":2
    },
      {
      "id": 3,
      "title":"A Study Of Palbociclib + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer",
      "created_by": "Dr.Jane Anderson",
      "description": "The study is designed to compare the clinical benefit following treatment with letrozole in combination with Palbociclib versus letrozole in combination with placebo in Asian postmenopausal women with ER(+)/HER2(-) advanced breast cancer who have not received prior systemic anti cancer therapies for their advanced/metastatic disease.",
      "Condition": "B+ve",
      "Sponsor": "Nagercoil",
      "Identified": 1,
      "Pre-Screened": 1,
      "Qualified":1,
      "Enrolled":2
    },
      {
      "id": 4,
      "title":"A Study Of Palbociclib + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer",
      "created_by": "Dr.Jane Anderson",
      "description": "The study is designed to compare the clinical benefit following treatment with letrozole in combination with Palbociclib versus letrozole in combination with placebo in Asian postmenopausal women with ER(+)/HER2(-) advanced breast cancer who have not received prior systemic anti cancer therapies for their advanced/metastatic disease.",
      "Condition": "B+ve",
      "Sponsor": "Nagercoil",
      "Identified": 1,
      "Pre-Screened": 1,
      "Qualified":1,
      "Enrolled":2
    }
]
